Skip to main content
Skip to main content

Comment Now: FDA Proposes New Regulations for Animal Drug Labeling

Today the U.S. Food and Drug Administration is proposing new regulations to provide animal drug sponsors with predictable requirements for the labeling of prescription and over-the-counter new animal drugs, as well as new animal drugs for use in animal feeds. The proposed content and format of labeling would also benefit veterinarians, animal owners, and animal producers by providing a more consistent presentation of information on the safe and effective use of these new animal drugs.

Comment Now: FDA Proposes New Regulations for Animal Drug Labeling

Today the U.S. Food and Drug Administration is proposing new regulations to provide animal drug sponsors with predictable requirements for the labeling of prescription and over-the-counter new animal drugs, as well as new animal drugs for use in animal feeds. The proposed content and format of labeling would also benefit veterinarians, animal owners, and animal producers by providing a more consistent presentation of information on the safe and effective use of these new animal drugs.

FDA Announces Animal Biotechnology Webinar on Low-Risk Intentional Genomic Alterations in Animals for Food Use

Today the U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) is announcing new resources for people interested in the development of intentional genomic alterations (IGAs) in animals. These include a pre-recorded, on-demand webinar about the agency’s risk-based review process for IGAs in animals that may pose low risk, as well as revamped web resources for biotechnology products at CVM.

FDA Releases Draft Guidance on Bringing Remaining Approved Over-The-Counter Medically Important Antimicrobial Drugs Used for Animals Under Veterinary Oversight

Today, the U.S. Food and Drug Administration released draft guidance for industry (GFI) #263 to explain the recommended process for voluntarily bringing remaining approved animal drugs containing antimicrobials of human medical importance (i.e., medically important) under the oversight of licensed veterinarians by changing the approved marketing status from over-the-counter (OTC) to prescription (Rx). [Source: FDA 23 Sept 2019]